BUZZ-中期研究发现亨廷顿氏症药物安全，赛捷公司业绩攀升

Reuters06-11

((自动化翻译由路透提供，请见免责声明 ))

6月11日 - ** Sage Therapeutics 股价盘前上涨1.8%至11.10美元

** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。

** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著差异。

** 截至上次收盘，该股今年累计下跌49.7

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2442364780?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-11 19:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2442364780","market":"us","top_or_hot":-1,"title":"BUZZ-中期研究发现亨廷顿氏症药物安全，赛捷公司业绩攀升","media":"Reuters","content":"<html><body><p>((自动化翻译由路透提供，请见免责声明 ))</p><p>    6月11日 - ** <a href=\"https://laohu8.com/S/SAGE\">Sage Therapeutics</a>   股价盘前上涨1.8%至11.10美元</p><p>** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。</p><p>** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著差异。</p><p>** 截至上次收盘，该股今年累计下跌49.7 </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-中期研究发现亨廷顿氏症药物安全，赛捷公司业绩攀升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-中期研究发现亨廷顿氏症药物安全，赛捷公司业绩攀升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-11 19:31 北京时间&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>((自动化翻译由路透提供，请见免责声明 ))    6月11日 - ** Sage Therapeutics   股价盘前上涨1.8%至11.10美元** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BUZZ","symbol_name":"VanEck Social Sentiment ETF","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2442364780","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2442364780","pubTimestamp":1718105472,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"((自动化翻译由路透提供，请见免责声明 ))    6月11日 - ** Sage Therapeutics   股价盘前上涨1.8%至11.10美元** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著差异。** 截至上次收盘，该股今年累计下跌49.7","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BUZZ":"VanEck Social Sentiment ETF","BK4139":"生物科技","SAGE":"Sage Therapeutics"},"translate_title":"BUZZ-Interim study finds Huntington's drug safe, Sage's performance climbs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BUZZ":1,"SAGE":0.9},"content_text":"((自动化翻译由路透提供，请见免责声明 ))    6月11日 - ** Sage Therapeutics   股价盘前上涨1.8%至11.10美元** 药物开发商称其药物dalzanemdor在一项名为亨廷顿氏病的罕见遗传性神经疾病患者的中期研究中被发现是安全的 (link)。** SAGE公司称，对亨廷顿病患者的研究并不是为了显示药物dalzanemdor与安慰剂之间存在统计学意义上的显著差异。** 截至上次收盘，该股今年累计下跌49.7","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2442364780"}